Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthma
- PMID: 7661491
- DOI: 10.7326/0003-4819-123-7-199510010-00002
Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthma
Abstract
Objective: To compare the action points in published asthma management plans with those derived from quality-control analysis of peak expiratory flow recordings.
Design: Longitudinal observational study.
Setting: An ambulatory asthma education and management program in a tertiary care hospital.
Patients: 35 adults with asthma and exacerbation of asthma.
Measurements: Peak expiratory flow diaries and symptom recordings.
Results: Asthma action points from published asthma management guidelines had poor operating characteristics. The success rate was 35% when the action point was a peak expiratory flow rate less than 60% of the patient's best peak flow. The success rate improved to 88% when the action point was a peak expiratory flow rate less than 80% of the patient's best peak flow. Published action points had a high failure rate. Peak flow decreased to below the published action points during a stable period of asthma in 7% to 51% of patients studied. Action points defined using quality-control analysis did significantly better. A peak flow value less than 3 standard deviations below the patient's mean peak flow detected 84% of exacerbations and had a low failure rate (19%). Other quality-control tests had sensitivities of 91% and 71%. Quality-control action points could detect exacerbations up to 4.5 days earlier than conventional methods.
Conclusions: Individualized action points can be derived for patients with asthma by applying quality-control analysis to peak flow recordings. These action points are more sensitive in detecting exacerbations of asthma and have fewer false-positive results. Action plans developed in this manner should be more useful for the early detection of deteriorating asthma.
Similar articles
-
Early detection of asthma exacerbations by using action points in self-management plans.Eur Respir J. 2013 Jan;41(1):53-9. doi: 10.1183/09031936.00205911. Epub 2012 May 31. Eur Respir J. 2013. PMID: 22653768
-
A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic.Am J Respir Crit Care Med. 1998 Feb;157(2):540-6. doi: 10.1164/ajrccm.157.2.9703060. Am J Respir Crit Care Med. 1998. PMID: 9476870 Clinical Trial.
-
End points in asthma.Can Respir J. 2003 Jan-Feb;10(1):9. doi: 10.1155/2003/142916. Can Respir J. 2003. PMID: 12624615 No abstract available.
-
Diurnal variability of peak expiratory flow.J Asthma. 2002 Aug;39(5):363-73. doi: 10.1081/jas-120004029. J Asthma. 2002. PMID: 12214890 Review.
-
Assessment of peak expiratory flow in asthma.Curr Opin Pulm Med. 1996 Jan;2(1):75-80. Curr Opin Pulm Med. 1996. PMID: 9363118 Review.
Cited by
-
Fluctuation-based clustering reveals phenotypes of patients with different asthma severity.ERJ Open Res. 2020 Jul 6;6(2):00007-2019. doi: 10.1183/23120541.00007-2019. eCollection 2020 Apr. ERJ Open Res. 2020. PMID: 32665951 Free PMC article.
-
Peak flow measurements in children with asthma: what happens at school?J Asthma. 2009 Aug;46(6):535-40. doi: 10.1080/02770900802468509. J Asthma. 2009. PMID: 19657891 Free PMC article. Clinical Trial.
-
Monitoring in chronic disease: a rational approach.BMJ. 2005 Mar 19;330(7492):644-8. doi: 10.1136/bmj.330.7492.644. BMJ. 2005. PMID: 15774996 Free PMC article. Review. No abstract available.
-
National Athletic Trainers' Association position statement: management of asthma in athletes.J Athl Train. 2005 Jul-Sep;40(3):224-45. J Athl Train. 2005. PMID: 16284647 Free PMC article.
-
Do practice guidelines augment drug utilisation review?Pharmacoeconomics. 1997 Dec;12(6):648-66. doi: 10.2165/00019053-199712060-00005. Pharmacoeconomics. 1997. PMID: 10175977
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical